4/A

PRIMARY DOCUMENT

Company: UNITED THERAPEUTICS Corp
Filed: September 29, 2015
Period of Report: June 26, 2015
Accession Number: 0001127602-15-027811

View Document ↗ View on SEC.gov ↗